CLAYTON, Mo., Jan. 8, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN), today announced an updated outlook for the fourth quarter 2025. Olin now expects fourth quarter 2025 adjusted EBITDA to be approximately $67 million compared to the previous outlook of $110 to $130 million. Most of the earnings shortfall occurred within the Chlor Alkali Products and Vinyls business, reflecting an extended planned maintenance turnaround and unplanned downtime at our Freeport, Texas operations, as well as lower-than-exp ...

RESPONSIBLE CARE® OUR COMMITMENT TO SUSTAINABILITY Refer to the Appendix for additional notices of caution regarding forward looking information. 2 TSX: CHE.UN 2026 Guidance 2026 Guidance: 2026 GUIDANCE Chemtrade Logistics Income Fund (TSX: CHE.UN) January 8, 2026 CAUTION REGARDING FORWARD- LOOKING STATEMENTS Certain statements contained in this presentation constitute forward-looking statements within the meaning of certain securities laws, including the Securities Act (Ontario). Forward-looking statements ...

Core Insights - Olin Corporation's shares have faced significant challenges, with a 48.69% decline over the past year, attributed to factors such as subsidized imports from Asia and Europe [4][9] - Teresa M. Vermillion, the VP & Treasurer, sold 4,500 shares through an option exercise, resulting in a 20.74% reduction in her direct ownership [7][9] - The company is focusing on its core chemical and ammunition segments, with a recent strategic partnership with Braskem aimed at enhancing growth in its vinyls business [10][11] Company Overview - Olin Corporation operates in the chemicals and ammunition sectors, generating revenue of $6.8 billion and a net income of $53.80 million [4][5] - The company has a dividend yield of 3.9% and has seen a 1-year price change of -48.69% [4] Transaction Details - The transaction involved the sale of shares at a weighted average price of approximately $20.86, with a total transaction value of around $93,850.20 [2][7] - Post-transaction, Vermillion holds 17,199 shares, valued at approximately $353,783.43 [2][7] Market Context - The company's stock performance has been negatively impacted by subdued global demand in the epoxy market and lower-than-expected ammunition sales [10] - The recent insider transaction is viewed as administrative rather than indicative of the company's future performance [7][9]

Core Viewpoint - Warren Buffett will step down as CEO of Berkshire Hathaway at the end of the year, but before his departure, the company plans to make a significant acquisition of OxyChem from Occidental Petroleum for $9.7 billion in cash [1][2]. Company Acquisition Details - Berkshire Hathaway is acquiring OxyChem, a leading petrochemical company known for producing caustic soda, potash, chlor-alkali, and PVC, with 23 facilities globally [5]. - The acquisition is valued at $9.7 billion, which is approximately 8 times OxyChem's expected EBITDA for 2025, aligning with valuations of other chemical stocks despite the industry facing lower earnings multiples [7]. Industry Context - The petrochemical industry is currently experiencing pressure, with weak pricing for caustic soda and PVC leading to disappointing pre-tax earnings of $213 million in the second quarter, prompting management to revise full-year pre-tax income expectations to between $800 million and $900 million [5][6]. - Occidental's management anticipates that supply-side pricing pressures will ease next year, projecting $1 billion in incremental pre-tax cash flow from non-oil and gas sources by 2026, aided by modernization efforts at OxyChem facilities [6]. Strategic Timing - Berkshire Hathaway's acquisition comes at a time when the petrochemical industry is near a cyclical trough, allowing the company to capitalize on a favorable buying opportunity [8].

Core Viewpoint - Occidental Petroleum is undergoing a transformational transaction with Berkshire Hathaway acquiring its chemicals subsidiary, OxyChem, for $9.7 billion, which will significantly reshape Occidental's business and financial profile [1][2][6]. Group 1: Transaction Details - Berkshire Hathaway is purchasing OxyChem for $9.7 billion in cash, which is a global manufacturer of essential commodity chemicals [3]. - OxyChem operates 23 facilities worldwide and produces key items such as caustic soda and PVC [3]. - The acquisition is expected to enhance OxyChem's profitability, with an anticipated $325 million increase in annualized EBITDA by 2026 due to ongoing investments [4]. Group 2: Financial Implications for Occidental - Occidental plans to use $6.5 billion of the proceeds from the sale to repay debt, aiming to reduce its principal debt below $15 billion [6][9]. - Achieving this debt reduction will save Occidental over $350 million annually in interest expenses, thereby boosting its free cash flow [9]. - The remaining $1.5 billion will enhance Occidental's financial flexibility, allowing for opportunistic share repurchases and additional debt repayments [9]. Group 3: Strategic Focus - The sale of OxyChem will allow Occidental to sharpen its focus on oil and gas production, unlocking significant low-cost resources [10][11]. - This strategic shift is expected to create long-term growth potential for Occidental as it concentrates on developing its vast oil and gas resources [11].

Core Insights - Berkshire Hathaway is acquiring Occidental Petroleum's chemical unit, OxyChem, for $9.7 billion in cash, marking its largest deal in three years just before Warren Buffett's retirement as CEO [1][9] - Berkshire has significantly increased its stake in Occidental Petroleum, reaching 32.7% by August 2025, making it the sixth-largest holding in its portfolio [2] - The acquisition focuses solely on OxyChem, a key manufacturer of chemicals, rather than full control of Occidental [3] Financial Performance - OxyChem generated $1.1 billion in operating income for the fiscal year ending December 31, 2024, contributing approximately 16% to Occidental's total income [6] - Occidental's capital expenditures for OxyChem are projected to rise by $200 million to $900 million in 2025, indicating a commitment to growth in this segment [6] Debt and Financial Strategy - The sale of OxyChem will provide Occidental with $6.5 billion to repay debt, enhancing its balance sheet and allowing for potential share repurchases and dividend growth [7] - Occidental's debt concerns have been exacerbated by its $12 billion acquisition of CrownRock in 2024, primarily financed through borrowing [7] Market Implications - The divestiture of OxyChem will position Occidental as a more focused oil and gas company, increasing its vulnerability to fluctuations in commodity prices [8]

Financial Data and Key Metrics Changes - In Q2 2025, adjusted EBITDA declined by 5% compared to Q2 2024, primarily due to a $32 million headwind from planned maintenance turnaround costs in the chemicals business [18] - Operating cash flow exceeded $212 million, funding the acquisition of a new ammunition facility, paying down $39 million of debt, and repurchasing $10 million of shares [7][20] - The company expects working capital to be a source of at least $100 million in cash for 2025, excluding tax payment timing [20] Business Line Data and Key Metrics Changes - The Chlor Alkali Products and Vinyls segment saw stable domestic caustic soda demand, with robust global demand for caustic soda into alumina [8] - The epoxy business experienced sequential growth in both volume and margin, despite ongoing challenges in the building and construction, automotive, and consumer electronics sectors [10][11] - Winchester's defense business continued to grow, driven by strong domestic military ammunition demand, while the commercial ammunition business faced challenges due to high retail inventories and weak consumer demand [12] Market Data and Key Metrics Changes - EDC pricing declined significantly, dropping more than 50% year-to-date, with expectations for stabilization in Q3 [31][34] - The company noted that tariff impacts on the chlor alkali business are generally neutral, but potential retaliatory tariffs could shift this balance [9][74] - The company highlighted that the market for caustic soda remains stable, with no deterioration in global demand [91] Company Strategy and Development Direction - The company is committed to a "value first" commercial approach, focusing on preserving value across integrated ECU products despite ongoing trough demand conditions [5] - The "Beyond 250" cost savings initiative aims to achieve annual cost savings of $70 million to $90 million by optimizing operations and reducing reliance on outside contractors [14][42] - The company is focused on maintaining a disciplined capital allocation approach, prioritizing investment-grade balance sheet maintenance, sustaining capital spending, and returning free cash flow to shareholders [21] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for Q3, expecting seasonal demand strength across businesses, with adjusted EBITDA projected between $170 million and $210 million [25][23] - The management acknowledged the challenges posed by higher commodity costs and the need for price increases to recover margins in the Winchester segment [46][48] - Management indicated that the current challenges in the commercial ammunition business are not structural and are expected to improve over time [12][45] Other Important Information - The company experienced several unplanned operating events that limited results to the lower end of expectations [7] - The acquisition of the Manitowoc ammunition facility is expected to generate $5 million of incremental adjusted EBITDA in 2025 and $40 million by year three [12] Q&A Session Summary Question: Progress of caustic soda price increase - Management noted ongoing strength in caustic soda supply and demand, with some short-term headwinds due to tariff uncertainties [27] Question: EDC pricing and potential support - Management acknowledged lower-than-expected EDC prices but expressed confidence in a floor due to curtailments in Asia and stable oil prices [32] Question: Winchester commercial pricing and cost headwinds - Management indicated that the decline in Winchester's commercial business is driven by volume and pricing pressures, with propellant costs continuing to be a headwind [36] Question: Cost savings program details - Management expects to realize $50 million to $70 million in cost savings for 2025, with additional structural cost reductions anticipated in 2026 [42] Question: Outlook for Winchester and potential worsening conditions - Management does not foresee further deterioration in Winchester, emphasizing that current challenges are temporary and not structural [45] Question: Impact of tariffs on chlor alkali operating rates - Management indicated that tariffs are currently neutral for chlor alkali, but significant retaliatory tariffs could pose a risk [74] Question: Customer inventory levels and destocking - Management reported that customers have not begun restocking and are focused on cash generation, with no significant changes in inventory behavior [81]

Financial Data and Key Metrics Changes - In the second quarter of 2025, adjusted EBITDA declined by 5% compared to the previous year, primarily due to a $32 million headwind from planned maintenance turnaround costs in the chemicals business [16][19] - Operating cash flow exceeded $212 million, funding the acquisition of a new ammunition facility, paying down $39 million of debt, and repurchasing $10 million of shares [5][18] Business Line Data and Key Metrics Changes - The chemicals business faced operational headwinds but managed to generate stable cash flow, with caustic soda demand remaining robust [6][16] - The epoxy resins segment saw sequential growth in both volume and margin, despite ongoing challenges in the building and construction sectors [9][10] - Winchester's defense business continued to grow, driven by strong domestic military demand, while the commercial ammunition business faced challenges due to high costs and weak consumer demand [11][12] Market Data and Key Metrics Changes - North American chlorine index values remained stable and higher than previous troughs, despite ongoing demand challenges [4][6] - EDC pricing experienced a significant decline, dropping more than 50% year-to-date, with expectations for stabilization in the third quarter [28][30] Company Strategy and Development Direction - The company is committed to a "value first" commercial approach, focusing on maintaining profitability during trough demand conditions [4][5] - The "Beyond 250" cost savings initiative aims to achieve $70 million to $90 million in annual savings by optimizing operations and reducing costs [13][37] - The company is exploring strategic options for its PBC market participation, leveraging its integrated VCM assets [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the third quarter, expecting seasonal demand strength across businesses, although macroeconomic uncertainties remain [21][22] - The company anticipates that the challenges in the commercial ammunition market are not structural and expects improvements as destocking pressures ease [11][41] - Management highlighted the importance of addressing rising costs and the need for price increases to restore margins in the Winchester segment [32][42] Other Important Information - The company is focused on maintaining a disciplined capital allocation approach, prioritizing investment-grade balance sheets, sustaining capital spending, and returning free cash flow to shareholders [19][20] - The company is actively managing operational challenges, including a chlorine leak incident, and is committed to improving safety and reliability [7][73] Q&A Session Summary Question: Progress of caustic soda price increase - Management noted that the caustic soda market remains tight, driven by stable demand and supply issues related to tariffs, which may cause temporary headwinds [24][26] Question: EDC pricing decline and potential support - Management acknowledged the unexpected drop in EDC prices but expressed confidence in reaching a floor due to curtailments in Asia and stable oil prices [30] Question: Winchester commercial pricing and cost pressures - Management indicated that the decline in Winchester's commercial business is driven by volume and pricing pressures, with ongoing cost headwinds from metals and propellants [32][33] Question: Cost savings program details - Management expects to achieve $50 million to $70 million in cost savings for 2025, with additional structural reductions anticipated in 2026 [37] Question: Future outlook for Winchester and potential risks - Management does not foresee worsening conditions for Winchester but emphasized the need for price recovery to address margin pressures [41][42] Question: Impact of tariffs on caustic soda exports - Management discussed the potential impact of retaliatory tariffs from Brazil on caustic soda exports, noting that trade flows would need to be adjusted if such tariffs were implemented [66][72] Question: Clarification on working capital and tax payments - Management provided insights into expected cash taxes for 2025 and clarified the relationship between deferred tax burdens and working capital benefits [94]

Financial Performance - Olin's Q2 2025 sales were $980 million[10], compared to $920 million in Q2 2024[10] and $925 million in Q1 2025[10] - Adjusted EBITDA for Q2 2025 was $171 million[10], down from $205 million in Q2 2024[10] and $186 million in Q1 2025[10] - Olin generated $212 million in operating cash flow[9] Segment Performance - Chlor Alkali Products & Vinyls (CAPV) sales were $331 million in Q2 2025[17], slightly down from $332 million in Q1 2025[17], and up from $318 million in Q2 2024[17] Adjusted EBITDA was negative $11 million[17] - Epoxy sales were $448 million in Q2 2025[23], up from $388 million in Q1 2025[23] and $406 million in Q2 2024[23] Adjusted EBITDA was $33 million[23] - Winchester sales were $176 million in Q2 2025[36] Outlook and Initiatives - Olin expects Q3 2025 Adjusted EBITDA to be between $170 million and $210 million[45] - The company is targeting $70-$90 million in annualized run rate savings by year-end 2025 through the Beyond250 initiative[30] - Olin expects working capital, excluding tax payment timing, to be greater than $100 million source of cash in 2025[43]

Core Insights - Olin reported Q2 2025 revenue of $1,758.3 million, exceeding analyst expectations by 6.0% but posted a GAAP loss per share of ($0.01), missing the consensus forecast of a $0.01 profit [1][2] - Adjusted EBITDA fell 36.6% to $176.1 million compared to the same period last year, indicating profitability pressures from rising input costs and maintenance expenses [1][2] Financial Performance - Revenue increased by 7.0% year-over-year from $1,644.0 million in Q2 2024 to $1,758.3 million in Q2 2025 [2] - Chlor Alkali Products and Vinyls revenue rose 6.4% to $979.5 million, while Epoxy revenue grew 4.2% to $331.2 million, and Winchester revenue increased 10.2% to $447.6 million [2][5][6][7] - GAAP EPS decreased by 101.6% from $0.62 in Q2 2024 to ($0.01) in Q2 2025, while adjusted EBITDA dropped from $278.1 million to $176.1 million [2][5] Business Segments Overview - The Chlor Alkali segment faced a 34.6% decline in earnings due to lower prices and higher maintenance costs, despite increased volumes [5] - The Epoxy segment experienced a deeper operating loss driven by rising costs and global oversupply, with flat profit margins year-over-year [6] - Winchester's sales rose due to military shipments, but earnings declined approximately 64% due to weak commercial sales and rising raw material costs [7] Strategic Focus - Olin is concentrating on maximizing value in its Chlor Alkali business, enhancing integration in Epoxy, and expanding the Winchester military channel [4] - Key success factors include maintaining low production costs, securing long-term military contracts, and effective capital allocation [4] Outlook - Management expects Q3 2025 adjusted EBITDA to range from $170 million to $210 million, indicating continued challenges [12] - Capital expenditures for 2025 have been trimmed by $25 million as part of cost control measures, with no upward revision to full-year earnings expectations [12]